NCT06590623View on ClinicalTrials.gov

The Effect of Acute Exogenous Oral Ketone Supplementation on Immune Cells Function and Immune Cells Histone Β-hydroxybutyrylation

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Ketosis, MetabolicImmune FunctionsHistone Deacetylase (HDAC) Activity
Interventions
DIETARY_SUPPLEMENT

Ketone Monoester (KE)

Participants will receive an exogenous ketone supplement (KetoneAid KE4) in a fasted state in the morning, at a dosage of 0.75 g/kg of body weight.

Trial Locations (1)

V1V1V7

RECRUITING

University of British Columbia Okanagan Campus, Kelowna

All Listed Sponsors
lead

University of British Columbia

OTHER